Patents by Inventor Liam O'Mahony

Liam O'Mahony has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Probiotic bifidobacterium strain
    Patent number: 10144978
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: December 4, 2018
    Assignee: Alimentary Health Ltd.
    Inventors: Liam O'Mahony, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
  • USE OF AKKERMANSIA MUCINIPHILA FOR TREATING INFLAMMATORY CONDITIONS
    Publication number: 20180296613
    Abstract: The invention relates to use of Akkermansia muciniphila, a mucin-degrading bacterial species found in the human gut, for treating undesirable inflammatory activity not caused by any metabolic disorder and/or obesity, especially for example undesirable airway inflammatory activity as seen with asthma.
    Type: Application
    Filed: October 5, 2016
    Publication date: October 18, 2018
    Applicant: SCHWEIZERISCHES FORSCHUNGSINSTITUT FUR HOCHGEBRIGSKLIMA UND MEDIZIN IN DAVOS
    Inventors: Liam O'Mahony, Cezmi A. Akdis, David Michalovich, Edith M. Hessel, James R. Brown, David N. Mayhew, Sorif Uddin
  • PROBIOTIC BIFIDOBACTERIUM STRAIN
    Publication number: 20180282825
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Application
    Filed: March 27, 2018
    Publication date: October 4, 2018
    Applicant: Alimentary Health Ltd.
    Inventors: Liam O'MAHONY, Barry KIELY, John Francis CRYAN, Timothy DINAN, Eileen Frances MURPHY
  • USE OF BIFIDOBACTERIUM LONGUM AND AN EXOPOLYSACCHARIDE PRODUCED THEREBY
    Publication number: 20180280453
    Abstract: Prophylaxis or treatment of allergic airway inflammatory activity is described using Bifidobacterium longum NCIMB 41003. Also described is an exopolysaccharide which comprises the structure Formula (I). The polysaccharide may be used for treating or preventing undesirable inflammatory activity.
    Type: Application
    Filed: August 26, 2016
    Publication date: October 4, 2018
    Applicant: Alimentary Health Limited
    Inventors: Liam O'MAHONY, Stephan PLATTNER, Friedrich ALTMANN, Paul KOSMA
  • PROBIOTIC BIFIDOBACTERIUM STRAIN
    Publication number: 20180202010
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Application
    Filed: May 10, 2012
    Publication date: July 19, 2018
    Applicant: Alimentary Health Ltd
    Inventors: Liam O'MAHONY, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
  • Bifidobacterium Longum
    Publication number: 20180016647
    Abstract: The multiple embodiments described herein comprise the genome of a probiotic Bifidobacterium longum bifidobacteria strain and genes encoded by the genome. Various novel Bifidobacterium longum are described.
    Type: Application
    Filed: August 23, 2017
    Publication date: January 18, 2018
    Inventors: Douwe Van Sinderen, Jun Xu, Wenzhu Zhao, Raymond A. Grant, Yuli Song, Charles Bascom, Duane Larry Charbonneau, Liam O'Mahony
  • Modulation of Tissue Fatty Acid Composition of a Host by Human Gut Bacteria
    Publication number: 20170313974
    Abstract: The current invention provides use of a CLA-producing bacterium for the in vivo conversion in the gut of polyunsaturated fatty acids to CLA. The CLA-producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria.
    Type: Application
    Filed: December 8, 2016
    Publication date: November 2, 2017
    Inventors: Liam O'Mahony, Fergus Shanahan, Eamonn Quigley, Paul Ross, Catherine Stanton
  • Bifidobacterium longum
    Patent number: 9771624
    Abstract: The multiple embodiments described herein comprise the genome of a probiotic Bifidobacterium longum bifidobacteria strain and genes encoded by the genome. Various novel Bifidobacterium longum are described.
    Type: Grant
    Filed: November 11, 2009
    Date of Patent: September 26, 2017
    Assignee: The Procter & Gamble Company
    Inventors: Douwe Van Sinderen, Jun Xu, Wenzhu (Steven) Zhao, Raymond A. Grant, Song Yuli, Charles Bascom, Duane Larry Charbonneau, Liam O'Mahony
  • Bifidobacterium longum
    Publication number: 20170058270
    Abstract: A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
    Type: Application
    Filed: August 26, 2016
    Publication date: March 2, 2017
    Inventors: Jose Carlos Garcia-Garcia, Michael John Janusz, Barry Kiely, Eileen Frances Murphy, Liam O'Mahony
  • strain
    Patent number: 9259019
    Abstract: Bifidobacterium strain AH121A is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: February 16, 2016
    Assignees: Mars, Incorporated, Alimentary Health Ltd.
    Inventors: Liam O'Mahony, Barry Kiely
  • PROBIOTIC BIFIDOBACTERIUM STRAINS
    Publication number: 20140328879
    Abstract: Probiotic Bifidobacterium strain AH1205 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity such as undesirable gastrointestinal inflammatory activity for example inflammatory bowel disease.
    Type: Application
    Filed: March 18, 2014
    Publication date: November 6, 2014
    Applicant: ALIMENTARY HEALTH LIMITED
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely
  • Probiotic strains
    Patent number: 8709398
    Abstract: Probiotic Bifidobacterium strain AH1205 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity such as undesirable gastrointestinal inflammatory activity for example inflammatory bowel disease.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: April 29, 2014
    Assignee: Alimentary Health Limited
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely
  • Probiotic bifidobacterium strains
    Patent number: 8557233
    Abstract: Bifidobacterium strain AH1206 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity for example undesirable gastrointestinal inflammatory activity such as inflammatory bowel disease.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: October 15, 2013
    Assignee: Alimentary Heath Limited
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely
  • Exopolysaccharide
    Patent number: 8357794
    Abstract: An isolated polysaccharide has the structure [-?(1,3)-D-GalpNAc-?(1,4)-D-Glcp-]n The polysaccharide may be from a Bifidobacterium strain NCIMB41003. The polysaccharide exhibits immunomodulatory activity.
    Type: Grant
    Filed: May 2, 2008
    Date of Patent: January 22, 2013
    Assignee: The Procter & Gamble Company and Alimentary Health Limited
    Inventors: Raymond Alan Grant, Liam O'Mahony, Barbara Sheil
  • BIFIDOBACTERIUM STRAIN
    Publication number: 20130004540
    Abstract: Bifidobacterium strain AH121A is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Application
    Filed: May 10, 2012
    Publication date: January 3, 2013
    Inventors: Liam O'mahony, Barry Kiely
  • PROBIOTIC BIFIDOBACTERIUM STRAIN
    Publication number: 20120276143
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Application
    Filed: May 10, 2012
    Publication date: November 1, 2012
    Inventors: Liam O'MAHONY, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
  • PROBIOTIC BIFIDOBACTERIUM STRAINS
    Publication number: 20120207713
    Abstract: Bifidobacterium strain AH1206 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity for example undesirable gastrointestinal inflammatory activity such as inflammatory bowel disease.
    Type: Application
    Filed: January 10, 2012
    Publication date: August 16, 2012
    Applicant: ALIMENTARY HEALTH LIMITED
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely
  • EXOPOLYSACCHARIDE
    Publication number: 20110046084
    Abstract: An isolated polysaccharide has the structure [-?(1,3)-D-GalpNAc-?(1,4)-D-Glcp-]n The polysaccharide may be from a Bifidobacterium strain NCIMB41003. The polysaccharide exhibits immunomodulatory activity.
    Type: Application
    Filed: May 2, 2008
    Publication date: February 24, 2011
    Inventors: Raymond Alan Grant, Liam O'mahony, Barbara Sheil
  • PROBIOTIC BIFIDOBACTERIUM STRAINS
    Publication number: 20110020400
    Abstract: Probiotic Bifidobacterium strain AH1205 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity such as undesirable gastrointestinal inflammatory activity for example inflammatory bowel disease.
    Type: Application
    Filed: March 28, 2008
    Publication date: January 27, 2011
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely
  • PROBIOTIC BIFIDOBACTERIUM STRAINS
    Publication number: 20110020284
    Abstract: Bifidobacterium strain AH1206 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity for example undesirable gastrointestinal inflammatory activity such as inflammatory bowel disease.
    Type: Application
    Filed: March 28, 2008
    Publication date: January 27, 2011
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely